Burckhardt advises selling shareholders in MIAC acquisition by Siena Imaging
Burckhardt advised the selling shareholders within the acquisition of MIAC, a Swiss clinical research company, by Italian startup Siena Imaging, which acquired 100% of MIAC’s shares.
MIAC
MIAC was a research-associated institution of the Universitätsspital Basel (USB). With its innovative and educational approach to clinical research, the Swiss company’s interests spanned over a plethora of activities, including radiological evaluations of various organ systems, validations of new examination methods, clinical data- management across all research phases, as well as second opinion assessments in the field of neuro-radiology.
The company was particularly renowned for its expertise in multiple sclerosis and other degenerative diseases.
Burckhardt’s team
Burckhardt, a Swiss law firm specialising in data protection, contract law, art law, M&A, and start-ups, served as legal advisor to the selling shareholders, overseeing all Swiss legal aspects of the transaction. The team included Mark Eichner, Alain Schmid, and Michael Giacomazzi-Weissen, all corporate and M&A.
PwC advised Siena Imaging over the reported transaction.
For more insights on the buyer side’s legal team, visit https://legalcommunity.it/pwc-tls-con-siena-imaging-nellacquisizione-della-svizzera-miac/